John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,088 shares at $118.61 ($248K) on 2016-12-12, disclosed to the SEC on 2016-12-13.
Open-market sale of $248k ALXN by EVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.61 | 1,044 | $124K | 50.0% |
| 2 | $118.61 | 1,044 | $124K | 50.0% |
| Total | $118.61 avg | 2,088 | $248K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |